Pharmaceutical Sciences

M.S., Ph.D. (Pharmaceutical Sciences)

401.874.2789

Faculty

Medicinal Chemistry and Pharmacognosy: Professors Cho and Parang; Associate Professors King, LaPlante, and Rowley; Assistant Professors Seeram and Udwary; Professor Emeritus Shimizu.

Pharmaceutics and Pharmacokinetics: Professors Kislalioglu, Lausier, and Rosenbaum; Associate Professor Akhlaghi; Assistant Professors Lu, Wang, and Worthen; Professors Emeriti Needham and Zia.

Pharmacoepidemiology and Pharmacoeconomics: Professors Larrat, Rosenbaum, and Temkin; Associate Professors Kogut, LaPlante, and Quilliam; Assistant Professor Caffrey; Clinical AssociateProfessor Marcoux.

Pharmacology and Toxicology: Professor Chichester, chair; Professors Parang, Rodgers, Shaikh, Yan, and Zawia; Associate Professors King and Deng; Assistant Professors Kovoor and Slitt; Assistant Research Professor Ahmed; Professor Emeritus Swonger.

Other Graduate Faculty: Professor Barbour, chair; Professors Dufresne, Hume, and Owens; Associate Professors Goren and Taviera; Clinical Associate Professors Bratberg and MacDonnell; Assistant Professor Cohen.

Specializations

Medicinal Chemistry and Pharmacognosy: Molecular mechanisms of chemical carcinogenesis; mutation and repair; combinatorial chemistry; solid-phase peptide synthesis; screening, isolation, and structure elucidation of physiologically-active natural products; biosynthesis of microbial and plant natural products; herbal medicine; bioinformatics.

Pharmaceutics and Pharmacokinetics: Design, development, production, evaluation, and regulatory approval of pharmaceutical and self-care products as well as pharmacokinetic and pharmacodynamic studies using virtual, clinical, and preclinical data, often with an emphasis on population approaches.

Pharmacoepidemiology and Pharmacoeconomics: Health and economic outcomes research pertaining to pharmacotherapy as used in human populations. Specializations include medication adherence, decision and cost-effectiveness analyses, post-marketing surveillance, epidemiologic methods, and quality improvement and measurement.

Pharmacology and Toxicology: Mechanisms involved in disease states and their pharmacological intervention, and mechanisms of toxicity of environmental agents. Ongoing topics include the effects of hormonal imbalances on cardiac function and metabolism in hypertension, biomarkers and treatment of arthritis, developmental neurotoxicity of environmental agents, hepatotoxicity and nephrotoxicity of heavy metals, pharmacogenomics, drug interactions, drug metabolism and drug transporters, and the development of inhibitors to cell signaling events.

Master of Science

Admission requirements: GRE and Pharm.D. or bachelor’s degree in pharmacy, chemistry, biological sciences, or allied sciences; TOEFL (waived for applicants from countries where English is the primary language).

Program requirements: Successful completion of 30 credits of graduate study, including PHC 502, 2 seminar credits, 6-9 thesis research credits, thesis.

For specialization in medicinal chemistry and pharmacognosy: ACS placement exam (organic) to determine specific program requirements; either BPS 530 or BPS 535; nine credits selected from CHM 427, 521, 522; BCH 581; BPS 525 and 551, and BPS 691A in consultation with students major professor.

For specialization in pharmaceutics and pharmacokinetics: STA 409 or 411 or equivalent; 6-9 credits of 500- or 600-level BPS courses; 3-6 credits of elective in consultation with students major professor.

For specialization in pharmacoepidemiology and pharmacoeconomics: PHP 540, and 550 or 580; six credits of STA 409, 411, or 412; six to nine credits of PHC 599; four to nine elective credits in consultation with student’s major professor.

For specialization in pharmacology and toxicology: BCH 581; one course of either BPS 530, 535, or 587; and three courses from BPS 525, 544, 546, 572, 587, 641, 644, and BCH 582, in consultation with student’s major professor.

Doctor of Philosophy

Admission requirements: GRE and master’s degree in pharmacy, chemistry, biological sciences, or allied sciences, or bachelor’s degree in one of these areas with evidence of superior ability. Qualifying examination is required for candidates accepted without the master’s degree. Qualified students may be admitted directly to the Ph.D. program.

Program requirements: Successful completion of 72 credits of graduate study, including up to 24 research credits, PHC 502, written and oral comprehensive examination, dissertation. Students are expected to attend and participate in the departmental seminars during their entire tenure in the Ph.D. program, for a maximum of three credits assigned to the core credit requirement.

For specialization in medicinal chemistry and pharmacognosy: ACS placement exam (organic) to determine specific program requirements; courses required for master’s degree, plus one additional credit from BPS 523 or 524, in consultation with students major professor.

For specialization in pharmaceutics and pharmacokinetics: M.S. core requirements, plus one additional credit from BPS 523 or 524, 12 credits of 500- or 600-level BPS or PHP courses, and 12 credits of concentration courses. Suggested courses include analytical chemistry, immunology, human genetics, and statistics of clinical trials, microbiology, and BPS 525, in consultation with student’s major professor.

For specialization in pharmacoepidemiology and pharmacoeconomics: PHP 540, 550, and 580 or 640; six credits of STA 409, 411, or 412; six credits of PSY 533, STA 502, 535, 536, 541, or 542; thirty-six credits from either PHC 697, 698 or 699, or additional 500/600 level elective courses determined in consultation with the major professor; elective credits in consultation with student’s major professor. Tutorials may be arranged in areas of special interest to the student, in consultation with student’s major professor.

For specialization in pharmacology and toxicology: courses required for master’s degree plus one additional credit from BPS 523 or 524; BPS 530, 535; two additional graduate-level courses from BPS or BCH /582, in consultation with student’s major professor.

Joint Doctor of Pharmacy/Master of Business Administration Program

The University of Rhode Island Colleges of Pharmacy and Business Administration offer a joint program that allows students the opportunity to develop management and administrative skills as they study for the Doctor of Pharmacy (Pharm.D.) degree. This program qualifies individuals to assume leadership and management roles in the health care industry. A unique combination of management and pharmacy coursework, coupled with innovative practicum experiences, provides students with a knowledge base of theoretical and applied information. The joint program requires the student to complete a total of 224 credits.

Students enrolled in the Doctor of Pharmacy program are eligible to apply for admission to the joint program after their second professional year (by July 15). The following are required at that time: GMAT, statement of purpose, résumé, two letters of recommendation, and TOEFL (waived for applicants from countries where English is the primary language).

Joint Doctor of Pharmacy/Master of Science Degree Program

The University of Rhode Island College of Pharmacy offers a joint program that allows students the opportunity to pursue the Master of Science degree while studying for the Doctor of Pharmacy degree. Students may elect to study in any one of the four specialization areas described in the graduate program: medicinal chemistry and pharmacognosy, pharmaceutics and pharmacokinetics, pharmacoepidemiology and pharmacoeconomics, or pharmacology and toxicology.

This program is designed for highly qualified and motivated students who are interested in simultaneously pursuing the Pharm.D. and M.S. degrees. Students are expected to complete the Pharm.D. program as described in this catalog. In addition, students must complete all additional credits required for the M.S. degree, complete a research project, and write and defend a thesis. It is expected that the motivated student will be enrolled during the summer sessions after the fourth, fifth, and sixth years with the objective of completing both degrees at the same time or in one additional semester.

Students enrolled in the Doctor of Pharmacy program are eligible to apply for admission to this joint degree program in the second semester of their first professional year (by May 1). The following are required at that time: statement of purpose, résumé, and two letters of recommendation.